Your browser doesn't support javascript.
loading
Structural characterization of ß-propiolactone inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles.
Bagrov, Dmitry V; Glukhov, Grigory S; Moiseenko, Andrey V; Karlova, Maria G; Litvinov, Daniil S; Zaitsev, Petr А; Kozlovskaya, Liubov I; Shishova, Anna A; Kovpak, Anastasia A; Ivin, Yury Y; Piniaeva, Anastasia N; Oksanich, Alexey S; Volok, Viktor P; Osolodkin, Dmitry I; Ishmukhametov, Aydar A; Egorov, Alexey M; Shaitan, Konstantin V; Kirpichnikov, Mikhail P; Sokolova, Olga S.
Afiliação
  • Bagrov DV; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Glukhov GS; Faculty of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
  • Moiseenko AV; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Karlova MG; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Litvinov DS; N. N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia.
  • Zaitsev PА; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Kozlovskaya LI; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Shishova AA; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Kovpak AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.
  • Ivin YY; Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Piniaeva AN; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.
  • Oksanich AS; Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Volok VP; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.
  • Osolodkin DI; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.
  • Ishmukhametov AA; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.
  • Egorov AM; Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
  • Shaitan KV; Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
  • Kirpichnikov MP; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.
  • Sokolova OS; Faculty of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
Microsc Res Tech ; 85(2): 562-569, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34498784
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propiolactona / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Propiolactona / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article